US2013075273A1PendingUtilityA1
On Demand Carbon Monoxide Generator For Therapeutic and Other Applications
Est. expirySep 28, 2031(~5.2 yrs left)· nominal 20-yr term from priority
C25B 1/23C25B 9/00C25B 1/00
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A device that can produce carbon monoxide for therapeutic and laboratory applications is disclosed. The device includes and electrochemical cell that converts carbon dioxide or a carbon dioxide containing molecule such as a carbonate or bicarbonate or bicarbonate into carbon monoxide and oxygen. The cell contains additives so pure carbon monoxide is obtained.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An carbon monoxide generator for chemical laboratory or therapeutic uses, comprising
a. A Carbon Dioxide Source, and b. A means to convert carbon dioxide to carbon monoxide,
wherein the output of the carbon monoxide generator contains at least 20 times as much CO as H 2 on a molar basis.
2 . The carbon monoxide generator in claim 1 with a Carbon Dioxide Source comprising at least one of solid CO 2 , liquid CO 2 , gaseous CO 2 , a carbonate or a bicarbonate.
3 . The carbon monoxide generator in claim 1 comprising an electrochemical cell
4 . The carbon monoxide generator in any of the preceding claims, comprising at least one of a) a Helper Catalyst b) A Directing Molecule or c) a Hydrogen Suppressor.
5 . The Carbon Dioxide Source in claim 1 comprising at least one of a) a Helper Catalyst b) A Directing Molecule or c) a Hydrogen Suppressor.
6 . The device in claim 4 or 5 , with at least one of
a) the Helper Catalyst,
b) The Directing Molecule or
c) the Hydrogen Supressor
comprising at least one cation and/or at least one anion.
7 . The device in any of claim 4 , 5 , or 6 wherein at least one of
a) the Helper Catalyst,
b) The Directing Molecule or
c) the Hydrogen Supressor
has a concentration of between about 0.000006 2% and 99.999% by weight.
8 . The device of any of claims 4 - 7 , wherein at least one of
a) the Helper Catalyst, b) The Directing Molecule or c) the Hydrogen Supressor comprises at least one of the following: phosphines, imidazoliums, pyridiniums, pyrrolidiniums, phosphoniums, sulfoniums, prolinates, methioninates, or alkali ions.
9 . The device of any of claims 4 - 8 , wherein at least one of
a) the Helper Catalyst, b) The Directing Molecule or c) the Hydrogen Supressor comprises cholines or a choline salt.
10 . The device of any one of claims 4 through 9 wherein at least one of
a) the Helper Catalyst,
b) The Directing Molecule or
c) the Hydrogen Supressor
comprises 1-ethyl-3-methylimidazolium cations.
11 . The device of any of claims 4 through 10 wherein at least one of
a) the Helper Catalyst,
b) The Directing Molecule or
c) the Hydrogen Supressor
comprises tetrafluoroborate anions.
12 . The device of any of claims 4 through 11 , wherein at least one of
a) the Helper Catalyst,
b) The Directing Molecule or
c) the Hydrogen Supressor
comprises potassium or cesium cations.
13 . The device of any of claims 4 through 12 , wherein at least one of
a) the Helper Catalyst,
b) The Directing Molecule or
c) the Hydrogen Supressor
comprises tetrafluoroborate anions, and
is a solvent, electrolyte or additive.
14 . The device of any of claims 4 through 13 above, wherein the Director Molecule comprises:a positively charges species further comprising at least one polar group selected from —OR, —COR, —COOR, —NR 2 , —PR 2 , —SR, or halides, where the R groups can independently be hydrogen or ligands containing carbon.
15 . The device of any of claims 4 through 14 above, wherein the Hydrogen Suppressor comprises: a choline derivative of the form R 1 R 2 R 3 N + (CH 2 ) n OH or R 1 R 2 R 3 N + (CH 2 ) n Cl, wherein n=1-4, and R 1 , R 2 , and R 3 are independently selected from the group consisting of aliphatic C 1 -C 4 groups, —CH 2 OH, —CH 2 CH 2 OH, —CH 2 CH 2 CH 2 OH, —CH 2 CHOHCH 3 , —CH 2 COH, —CH 2 CH 2 COH, and —CH 2 COCH 3 and molecules where one or more chlorine or fluorine is substituted for hydrogen in aliphatic C 1 -C 4 groups, —CH 2 OH, —CH 2 CH 2 OH, —CH 2 CH 2 CH 2 OH, —CH 2 CHOHCH 3 , —CH 2 COH, —CH 2 CH 2 COH, or —CH 2 COCH 3 . 16 A portable carbon monoxide generator for chemical laboratory or therapeutic use, comprising the device of any of the above claims.
16 . The device of any of claims 2 through 14 above wherein the device comprises a cartridge that fits in the line between an oxygen source and a patient.
17 . A method of producing carbon monoxide for chemical laboratory or therapeutic uses, comprising the steps of:
providing the device of any of the above claims; providing carbon dioxide, a carbonate, or a bicarbonate from the Carbon Dioxide Source to the device; providing any additional water, solvent, or electrolyte as may be needed; applying a source of energy, such as an electric current, to the device; and directing the carbon monoxide thus produced to the intended point of use.Join the waitlist — get patent alerts
Track US2013075273A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.